Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Amyris

21 Disclosed Funding Rounds $1,120,315,856

0 Participating Investments


Chemical, Biotechnology, CleanTech, Renewable Energy

Amyris Biotechnologies specializes in creating renewable products focusing on fuels and chemicals.

Emeryville, California, United States, North America (US)

Organizations in Emeryville in Chemical,
Organizations in Emeryville in Biotechnology,
Organizations in Emeryville in CleanTech,
Organizations in Emeryville in Renewable Energy,
Organizations in California in Chemical,
Organizations in California in Biotechnology,
Organizations in California in CleanTech,
Organizations in California in Renewable Energy,
Organizations in United States in Chemical,
Organizations in United States in Biotechnology,
Organizations in United States in CleanTech,
Organizations in United States in Renewable Energy,
Organizations in North America in Chemical,
Organizations in North America in Biotechnology,
Organizations in North America in CleanTech,
Organizations in North America in Renewable Energy

Investors in Emeryville in Chemical,
Investors in Emeryville in Biotechnology,
Investors in Emeryville in CleanTech,
Investors in Emeryville in Renewable Energy,
Investors in California in Chemical,
Investors in California in Biotechnology,
Investors in California in CleanTech,
Investors in California in Renewable Energy,
Investors in United States in Chemical,
Investors in United States in Biotechnology,
Investors in United States in CleanTech,
Investors in United States in Renewable Energy,
Investors in North America in Chemical,
Investors in North America in Biotechnology,
Investors in North America in CleanTech,
Investors in North America in Renewable Energy

West Coast (0 Investors) (0 Startups), Western US (0 Investors) (0 Startups), San Francisco Bay Area (0 Investors) (0 Startups)

Founded date 01, 2003

Founders Jack Newman, Neil Renninger, Kinkead Reiling, Vince Martin

Operating Status Active

Funding Stage IPO

Last Funding Type Post-IPO Equity

Also known as Amyris Biotechnologies

Company Type For Profit


Facebook Link

Twitter Link

LinkedIN Link

Wikipedia Link

Amyris Biotechnologies creates renewable products that focus on fuels and chemicals that provide no-compromise sustainable alternatives to a broad range of petroleum-sourced products. It uses an industrial synthetic biology platform that applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. Its technology creates products that support biopharmaceutical drug discovery and production, from cosmetic emollients and fragrances to fuels, solvents, lubricants, and nutraceuticals. The company was founded in 2003 and is headquartered in Emeryville, California.

Date Round Raised Lead
June, 07, 2020 Post-IPO Equity $200,000,000 -------
April, 30, 2019 Post-IPO Equity $34,000,000 Foris Ventures
August, 24, 2018 Post-IPO Equity $46,000,000 -------
January, 17, 2018 Grant $25,000,000 National Institutes of Health
August, 03, 2017 Post-IPO Equity $50,000,000 DSM Elastomers, Vivo Capital
October, 06, 2016 Post-IPO Debt $25,000,000 -------
October, 06, 2016 Post-IPO Equity $5,000,000 -------
October, 14, 2015 Convertible Note $57,600,000 -------
July, 29, 2015 Post-IPO Equity $140,979,458 Temasek Holdings, Total
July, 31, 2014 Post-IPO Debt $10,850,000 -------
June, 11, 2013 Post-IPO Debt $30,000,000 -------
February, 27, 2012 Post-IPO Equity $83,700,000 -------
February, 27, 2012 Post-IPO Equity Undisclosed -------
October, 28, 2011 Post-IPO Equity $7,000,000 -------
October, 12, 2010 Post-IPO Equity $13,778,480 -------
June, 26, 2010 Series D $133,000,000 Temasek Holdings
December, 01, 2009 Grant $24,300,000 -------
October, 01, 2009 Series C $41,750,000 -------
August, 14, 2008 Series B $21,000,000 -------
September, 19, 2007 Series B $70,000,000 DAG Ventures
October, 12, 2006 Series A $20,000,000 Khosla Ventures

Amyris Investors (34)

Investor Lead? Round Participating Raise Date Partners
John Doerr No Post-IPO Equity $34,000,000 April, 30, 2019 -------
Foris Ventures Yes Post-IPO Equity $34,000,000 April, 30, 2019 -------
Wei-Wu He No Post-IPO Equity $34,000,000 April, 30, 2019 -------
National Institutes of Health Yes Grant $25,000,000 January, 17, 2018 -------
DSM Elastomers Yes Post-IPO Equity $50,000,000 August, 03, 2017 -------
Vivo Capital Yes Post-IPO Equity $50,000,000 August, 03, 2017 -------
Temasek Holdings Yes Post-IPO Equity $140,979,458 July, 29, 2015 -------
Total Carbon Neutrality Ventures No Post-IPO Equity $140,979,458 July, 29, 2015 -------
Total Yes Post-IPO Equity $140,979,458 July, 29, 2015 -------
Biolding Investment No Post-IPO Equity $83,700,000 February, 27, 2012 -------
Naxyris No Post-IPO Equity $83,700,000 February, 27, 2012 -------
Total Gas & Power No Post-IPO Equity $83,700,000 February, 27, 2012 -------
Temasek Holdings No Post-IPO Equity $83,700,000 February, 27, 2012 -------
Total Carbon Neutrality Ventures No Post-IPO Equity Undisclosed February, 27, 2012 -------
Procter & Gamble Company No Series D $133,000,000 June, 26, 2010 -------
Temasek Holdings Yes Series D $133,000,000 June, 26, 2010 -------
Cosan S.A. No Series D $133,000,000 June, 26, 2010 -------
Solliance No Series D $133,000,000 June, 26, 2010 -------
Total No Series D $133,000,000 June, 26, 2010 -------
TPG Growth No Series C $41,750,000 October, 01, 2009 -------
Votorantim Novos Negocios No Series C $41,750,000 October, 01, 2009 -------
Kleiner Perkins No Series C $41,750,000 October, 01, 2009 -------
Khosla Ventures No Series C $41,750,000 October, 01, 2009 -------
TPG Growth No Series B $21,000,000 August, 14, 2008 -------
Kleiner Perkins No Series B $21,000,000 August, 14, 2008 -------
Khosla Ventures No Series B $21,000,000 August, 14, 2008 -------
DAG Ventures No Series B $21,000,000 August, 14, 2008 -------
TPG Growth No Series B $70,000,000 September, 19, 2007 -------
Kleiner Perkins No Series B $70,000,000 September, 19, 2007 -------
Khosla Ventures No Series B $70,000,000 September, 19, 2007 -------
DAG Ventures Yes Series B $70,000,000 September, 19, 2007 -------
TPG Growth No Series A $20,000,000 October, 12, 2006 -------
Kleiner Perkins No Series A $20,000,000 October, 12, 2006 -------
Khosla Ventures Yes Series A $20,000,000 October, 12, 2006 -------